By correcting hyperhomocysteinemia and background in dyslipidemia of prolonged use of proton pump inhibitors

Abstract

Present article is devoted to the study of the new approaches to correction of hyperhomocysteinaemia and dyslipidemia associated with long-term use of proton pump inhibitors. A positive influence of statins on cholesterol and  homocysteine concentration is proved. At the same time the complex therapy that includes   parenteral B12 supplementation leads to more effective correction of hyperhomocysteinaemia and dyslipidemia in patients with comorbidity of ischemic heart disease and acid peptic disease with long-term use of proton pump inhibitors.